Partner
VALENCIA
Calendar
News
INCLIVA identifies AXL protein as a specific biomarker and therapeutic target in HER2+ breast cancer
Dr. Juan Miguel Cejalvo -researcher of the Breast Cancer Biology Research Group of the INCLIVA Health Research Institute of the Hospital Clínico de València, directed by Dr. Ana Lluch, and researcher member of CIBERONC-, has led a study in which a protein -called AXL-...
Collaboration and values to save the Mar Menor
There are environmental conflicts that brew slowly and invisibly over decades and suddenly, when certain thresholds are reached, come to light. In the case of the Mar Menor (Region of Murcia, Spain), the first warning sign was in the early 2000s, with the invasion of...
Expert Voices
Investigadora de los determinantes sociales del cáncer en FISABIO-Salud Pública
Coordinadora e investigadora del Área de Investigación en Enfermedades Raras de Fisabio
Projects EUCORNER
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.